Cedience is a Toronto-based company that specializes in augmented regulatory intelligence for the pharmaceutical and biotechnology sectors. Founded in 2019, Cedience leverages artificial intelligence to enhance drug development and streamline regulatory approval processes. The company centralizes and analyzes regulatory data from authorities like the FDA and EMA, helping teams avoid costly delays caused by regulatory surprises.

Cedience offers a Regulatory Intelligence Platform, a SaaS solution that automates the integration of regulatory databases. This platform features tools for document filtering, collaboration, and rapid precedent searches. Additionally, Cedience provides precedent analysis to guide development strategies and regulatory workflow tools for monitoring updates and analyzing intelligence gaps. The platform utilizes natural language processing and machine learning to interpret complex regulatory documents, enhancing data reporting and interpretation. Cedience’s mission is to bridge knowledge gaps in drug development, facilitating faster approvals and improved collaboration between innovators and regulators.